Founded in 2015, SynThera Biomedical operates in Health Tech industry. Initially focused on creating innovative medical devices for orthopaedic applications, the company has expanded its product line ...
Funding stage:
Seed
Last funding:
08/07/2018
Investors
Employee count:
9
Last 90d
9
Last 90d
Web traffic:
1.43K
1.43K
Last 30d
Last 30d
SynThera Biomedical: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders31
Latest Filing Date21 March 2021- Funding Events8
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of SynThera Biomedical
As of 22 March 2021, SynThera Biomedical's equity is held by 30 shareholders, with the top three being Nilay Lakhkar, Entrepreneurship Development Center, and Blue Ashva Sampada Fund.
Nilay Lakhkar holds the largest stake in SynThera Biomedical at 65.1% as of 22 March 2021.
As of 22 March 2021, founders collectively hold 65.8% equity in SynThera Biomedical.
As of 22 March 2021, investors collectively hold 25.4% equity in SynThera Biomedical.
SynThera Biomedical's ESOP pool stands at 7.7% of total equity as of 22 March 2021.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links